drugset / Trial / NCT00461331

Comparison of Insulins Aspart and Lispro in Insulin Pumps

NCT00461331

Phase 4 Completed 20 enrolled Tulane University Health Sciences Center
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of the study is to compare the glycemic control between insulins aspart and lispro 48 to 100 hours after pump infusion line change in subjects with type 1 using diabetes using an insulin pump.

Timeline

Start
2004-10
Primary completion
2007-06
Completion
2008-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Insulin Lispro Protein / enzyme biologic
Comparator insulin aspart Protein / enzyme biologic